- Home
- EPOW vs LGVN Comparison
EPOW vs LGVN Comparison
Compare EPOW & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- LGVN
- Stock Information
- Founded
- EPOW 2014
- LGVN 2014
- Country
- EPOW China
- LGVN United States
- Employees
- EPOW N/A
- LGVN N/A
- Industry
- EPOW Business Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- EPOW Consumer Discretionary
- LGVN Health Care
- Exchange
- EPOW Nasdaq
- LGVN Nasdaq
- Market Cap
- EPOW 27.0M
- LGVN 23.4M
- IPO Year
- EPOW 2021
- LGVN 2021
- Fundamental
- Price
- EPOW $0.94
- LGVN $1.36
- Analyst Decision
- EPOW
- LGVN Strong Buy
- Analyst Count
- EPOW 0
- LGVN 3
- Target Price
- EPOW N/A
- LGVN $8.67
- AVG Volume (30 Days)
- EPOW 14.4K
- LGVN 138.8K
- Earning Date
- EPOW 07-07-2025
- LGVN 08-13-2025
- Dividend Yield
- EPOW N/A
- LGVN N/A
- EPS Growth
- EPOW N/A
- LGVN N/A
- EPS
- EPOW N/A
- LGVN N/A
- Revenue
- EPOW $64,997,741.00
- LGVN $2,225,000.00
- Revenue This Year
- EPOW N/A
- LGVN N/A
- Revenue Next Year
- EPOW N/A
- LGVN $51.48
- P/E Ratio
- EPOW N/A
- LGVN N/A
- Revenue Growth
- EPOW 44.28
- LGVN 127.50
- 52 Week Low
- EPOW $0.55
- LGVN $1.14
- 52 Week High
- EPOW $1.36
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- EPOW 51.42
- LGVN 50.13
- Support Level
- EPOW $0.91
- LGVN $1.15
- Resistance Level
- EPOW $0.96
- LGVN $1.32
- Average True Range (ATR)
- EPOW 0.04
- LGVN 0.09
- MACD
- EPOW 0.00
- LGVN 0.01
- Stochastic Oscillator
- EPOW 60.00
- LGVN 45.31
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.